Ono Pharmaceutical Company, Ltd., a Japanese pharmaceutical firm, has ambitions to become a global specialty pharma company and has made a move to strengthen its geographic footprint. The company announced plans to acquire Waltham, MA-based Deciphera Pharmaceuticals, Inc. for $2.4bn, gaining a marketed cancer drug and a commercial presence in the US and Europe.
Ono revealed the acquisition on 29 April, agreeing to pay $25
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?